A Bitter Pill to Swallow: Why Medication Safety Is Critical in Hepatitis C Treatment.

Q1 Medicine
P and T Pub Date : 2018-12-01
Karyn M Sullivan, Linda M Spooner, Emily Harris, Kenneth Lowe, George M Abraham
{"title":"A Bitter Pill to Swallow: Why Medication Safety Is Critical in Hepatitis C Treatment.","authors":"Karyn M Sullivan,&nbsp;Linda M Spooner,&nbsp;Emily Harris,&nbsp;Kenneth Lowe,&nbsp;George M Abraham","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To provide medication safety tips to optimize the management of patients receiving treatment for chronic hepatitis C virus (HCV) infection.</p><p><strong>Summary: </strong>Ensuring safe medication use in patients who receive treatment for HCV infection is a crucial component in providing optimal patient care. Because of the complexity of available treatment options, numerous challenges exist in preventing medication errors with HCV therapies. This article will focus on the selection of appropriate treatment options along with proper dosing and duration, awareness of concomitant disease states and drug interactions, identifying adverse drug reactions (ADRs) and patient counseling points, the provision of adherence counseling and prevention of treatment interruptions, improving communication with patients and between pharmacies, and recognizing the importance of a multidisciplinary approach.</p><p><strong>Conclusion: </strong>Maintaining awareness of medication safety strategies geared toward HCV pharmacotherapy is critical for providing optimal care for patients while minimizing the opportunity for errors.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"764-768"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281151/pdf/ptj4312764.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"P and T","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To provide medication safety tips to optimize the management of patients receiving treatment for chronic hepatitis C virus (HCV) infection.

Summary: Ensuring safe medication use in patients who receive treatment for HCV infection is a crucial component in providing optimal patient care. Because of the complexity of available treatment options, numerous challenges exist in preventing medication errors with HCV therapies. This article will focus on the selection of appropriate treatment options along with proper dosing and duration, awareness of concomitant disease states and drug interactions, identifying adverse drug reactions (ADRs) and patient counseling points, the provision of adherence counseling and prevention of treatment interruptions, improving communication with patients and between pharmacies, and recognizing the importance of a multidisciplinary approach.

Conclusion: Maintaining awareness of medication safety strategies geared toward HCV pharmacotherapy is critical for providing optimal care for patients while minimizing the opportunity for errors.

Abstract Image

难以下咽的苦果:为什么药物安全对丙型肝炎治疗至关重要。
目的:提供药物安全提示,以优化慢性丙型肝炎病毒(HCV)感染患者的治疗管理。摘要:确保接受HCV感染治疗的患者安全用药是提供最佳患者护理的关键组成部分。由于现有治疗方案的复杂性,在预防丙肝病毒治疗的用药错误方面存在许多挑战。本文将侧重于选择适当的治疗方案,适当的剂量和持续时间,对伴随疾病状态和药物相互作用的认识,识别药物不良反应(adr)和患者咨询点,提供依从性咨询和预防治疗中断,改善与患者和药房之间的沟通,并认识到多学科方法的重要性。结论:保持对HCV药物治疗的药物安全策略的认识对于为患者提供最佳护理同时最大限度地减少错误的机会至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
P and T
P and T Medicine-Pharmacology (medical)
CiteScore
7.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信